Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure

Journal of Cardiac Failure

Volumn 21, Issue 2, 2015, Pages 91-96

  Tang, W H Wilson ^a   Wang, Zeneng ^a   Shrestha, Kevin ^a   Borowski, Allen G ^a   Wu, Yuping ^b   Troughton, Richard W ^c   Klein, Allan L ^a   Hazen, Stanley L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

diastolic dysfunction; heart failure; Intestinal microbiota; trimethylamine N oxide

Indexed keywords

BETAINE; BIOLOGICAL MARKER; CHOLINE; METHYLAMINE; PHOSPHATIDYLCHOLINE; TRIMETHYLOXAMINE;

ADULT; AGED; BLOOD PRESSURE; CHRONIC DISEASE; COHORT ANALYSIS; FEMALE; HEART FAILURE, SYSTOLIC; HUMAN; INTESTINE; MALE; METABOLISM; MICROFLORA; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; BETAINE; BIOMARKERS; BLOOD PRESSURE; CHOLINE; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; INTESTINES; MALE; METHYLAMINES; MICROBIOTA; MIDDLE AGED; PHOSPHATIDYLCHOLINES; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84921863158     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2014.11.006     Document Type: Article

References (21)

1. M.E. Dumas, R.H. Barton, A. Toye, O. Cloarec, C. Blancher, and A. Rothwell Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice Proc Natl Acad Sci U S A 103 2006 12511 12516
2. Z. Wang, E. Klipfell, B.J. Bennett, R. Koeth, B.S. Levison, and B. Dugar Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease Nature 472 2011 57 63
3. W.H. Tang, Z. Wang, B.S. Levison, R.A. Koeth, E.B. Britt, and X. Fu Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk N Engl J Med 368 2013 1575 1584
4. R.A. Koeth, Z. Wang, B.S. Levison, J.A. Buffa, E. Org, and B.T. Sheehy Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis Nat Med 19 2013 576 585
5. Z. Wang, W.H. Tang, J.A. Buffa, X. Fu, E.B. Britt, and R.A. Koeth Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide Eur Heart J 35 2014 904 910
6. W.H. Tang, Z. Wang, Y. Fan, B. Levison, J.E. Hazen, and L.M. Donahue Prognostic value of elevated levels of intestinal microbe-generated metabolite, trimethylamine-N-oxide (TMAO), in patients with heart failure: refining the gut hypothesis J Am Coll Cardiol 64 2014 1908 1914
7. W.H. Tang, W. Tong, K. Shrestha, Z. Wang, B.S. Levison, and B. Delfraino Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure Eur Heart J 29 2008 2506 2513
8. Z. Wang, B.S. Levison, J.E. Hazen, L. Donahue, X.M. Li, and S.L. Hazen Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry Anal Biochem 455C 2014 35 40
9. Z. Shao, Z. Wang, K. Shrestha, A. Thakur, A.G. Borowski, and W. Sweet Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1 J Am Coll Cardiol 59 2012 1150 1158
10. W.H. Tang, K. Shrestha, R.W. Troughton, A.G. Borowski, and A.L. Klein Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure Congest Heart Fail 17 2011 105 109
11. W.H. Tang, W. Tong, R.W. Troughton, M.G. Martin, K. Shrestha, and A. Borowski Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure J Am Coll Cardiol 49 2007 2364 2370
12. W.H. Tang, K. Shrestha, F. van Lente, R.W. Troughton, M.G. Martin, and A.G. Borowski Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure Am J Cardiol 101 2008 370 373
13. W.H. Tang, F. van Lente, K. Shrestha, R.W. Troughton, G.S. Francis, and W. Tong Impact of myocardial function on cystatin C measurements in chronic systolic heart failure J Card Fail 14 2008 394 399
14. A. Krack, R. Sharma, H.R. Figulla, and S.D. Anker The importance of the gastrointestinal system in the pathogenesis of heart failure Eur Heart J 26 2005 2368 2374
15. G. Rogler, and G. Rosano The heart and the gut Eur Heart J 35 2014 426 430
16. X.T. Gan, G. Ettinger, C.X. Huang, J.P. Burton, J.V. Haist, and V. Rajapurohitam Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat Circ Heart Fail 7 2014 491 499
17. A. Sandek, J. Bauditz, A. Swidsinski, S. Buhner, J. Weber-Eibel, and S. von Haehling Altered intestinal function in patients with chronic heart failure J Am Coll Cardiol 50 2007 1561 1569
18. A. Sandek, I. Bjarnason, H.D. Volk, R. Crane, J.B. Meddings, and J. Niebauer Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure Int J Cardiol 157 2012 80 85
19. F. Wang, Q. Li, Q. He, Y. Geng, C. Tang, and C. Wang Temporal variations of the ileal microbiota in intestinal ischemia and reperfusion Shock 39 2013 96 103
20. D.G. Souza, A.T. Vieira, A.C. Soares, V. Pinho, J.R. Nicoli, and L.Q. Vieira The essential role of the intestinal microbiota in facilitating acute inflammatory responses J Immunol 173 2004 4137 4146
21. A. Sandek, M. Rauchhaus, S.D. Anker, and S. von Haehling The emerging role of the gut in chronic heart failure Curr Opin Clin Nutr Metab Care 11 2008 632 639